Video Shorts

Navigating Treatment Selection After HMA Failure in Higher-Risk MDS

Navigating BTK Inhibitor Data for MCL and Important Next Steps for the Field

Spotlighting the Role of Cardio-Oncology in Breast Cancer Care

Unpacking Real-World Outcomes With ARP Inhibitor Therapy in mHSPC

Research Areas of Interest in Frontline Lower-Risk MDS

Inside the Most Notable Data in Prostate Cancer From ASCO GU 2026

Is Early-Onset CRC a Biologically Distinct Disease? Drs Marshall and Lieu Explore the Evidence

Previewing Integrative Medicine Conversations in Breast Cancer

Asking Breast Cancer Experts About the Most Inspirational Women in Their Life!

Previewing the Breast Cancer Briefing Podcast Series

Asking Experts Their Favorite Thing to do in Miami While at MBCC!

Highlights of the 2026 Women in Oncology Event

A Day in the Life of OncLive at MBCC!

Examining Caregiver Support in Prostate Cancer

Why Meetings Like the Miami Breast Cancer Conference Matter

Outcomes for Orca-T Plus Allogeneic CAR T-Cell Therapy in B-ALL

Unpacking the KEYNOTE-B15 Data

Navigating the Complexity of Acute Lymphoblastic Leukemia Management

Looking to the Future of TNBC Treatment Development and Sequencing

Implications of the FDA Approval of Daratumumab Plus VRd in Transplant-Ineligible Myeloma

Highlighting the Future of the HNSCC Treatment Paradigm

Reviewing ASCO GU 2026 and its Most Important Coverage

Why Is CRC Incidence Rising Among Younger, Fit Patients? Drs Marshall and Lieu Weigh In

Breaking Down the Top 2 Bladder Cancer Abstracts From ASCO GU: With Chandler Park, MD, FACP

Exploring the Mechanism of Action of FX909

Characterization of Responders to EV Plus Pembrolizumab in mUC

Targeted Therapy and Surgical Advances Move the Needle in Chondrosarcoma

Top 3 Trials in RCC You Won’t Want to Miss At ASCO GU 2026: With Chandler Park, MD, FACP

ASCO GU Attendees Preview the Top Abstracts, Personal Conference Must-Haves

Exploring Ipilimumab/Nivolumab Outcomes by Age in ccRCC